HUT72302A

Catecholamine surrogates useful as beta-3 antagonists

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

33 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
17128593United States of AmericaA
17128593United States of AmericaA
93171285–––
US19930171285–––

Members33

Family members, oldest first
DocumentOfficeKind
FI946003A0FinlandA0
NO944969D0NorwayD0
HU9403694D0HungaryD0
IL112060A0IsraelA0
IL112060D0IsraelD0
CA2138675A1CanadaA1
FI946003AFinlandA
NO944969LNorwayL
PL306452A1PolandA1
EP0659737A2European Patent Office (EPO)A2
AU8163594AAustraliaA
KR950017940ARepublic of KoreaA
JPH07206806AJapanA
CN1109050AChinaA
HUT72302AThis recordHungaryA
ZA9410213BSouth AfricaB
CZ326094A3CzechiaA3
RU94044343ARussian FederationA
EP0659737A3European Patent Office (EPO)A3
NZ270237ANew ZealandA
AU688417B2AustraliaB2
NO303337B1NorwayB1
US5776983AUnited States of AmericaA
SG50477A1SingaporeA1
TW424082BTaiwan Province of ChinaB
HU220063BHungaryB
EP0659737B1European Patent Office (EPO)B1
AT235463TAustriaT
ATE235463T1AustriaT1
DE69432341D1GermanyD1
ES2194857T3SpainT3
DE69432341T2GermanyT2
CA2138675CCanadaC